Submacular hemorrhage removal

Ophthalmology. 1995 Sep;102(9):1393-9. doi: 10.1016/s0161-6420(95)30858-5.

Abstract

Purpose: To determine whether pars plana vitrectomy combined with tissue plasminogen activator for evacuation of submacular hemorrhage results in improved visual acuity.

Methods: Retrospective review of 18 patients who received a subretinal injection of tissue plasminogen activator during a pars plana vitrectomy to evacuate dense submacular hemorrhages.

Results: Diagnoses included age-related macular degeneration (16 patients), ruptured macroaneurysm (1 patient), and penetrating ocular trauma (1 patient). Preoperative visual acuity ranged from 20/200 to counting fingers (median visual acuity, counting fingers). Follow-up ranged from 10 to 104 weeks (median, 33 weeks). Best postoperative visual acuity ranged from 20/30 to counting fingers (median, 20/300). Best postoperative visual acuity improved two or more lines in 11 (61%) of 18 eyes, remained unchanged in 4 (22%) of 18 eyes, and decreased two or more lines in 3 (17%) of 18 eyes (P = 0.10, Wilcoxon sign-rank test). Final visual acuity ranged from 20/40 to light perception (median, counting fingers). Final visual acuity improved two or more lines in 5 (28%) of 18 eyes, remained unchanged in 6 (33%) of 18 eyes, and decreased two or more lines in 7 (39%) of 18 eyes (P = 0.53, Wilcoxon sign-rank test).

Conclusions: Pars plana vitrectomy to evacuate massive subretinal hemorrhage can improve visual acuity, but final visual acuity is limited by the underlying disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Choroid / blood supply
  • Choroid / surgery
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Injections
  • Macula Lutea*
  • Macular Degeneration / complications
  • Male
  • Middle Aged
  • Neovascularization, Pathologic / complications
  • Neovascularization, Pathologic / surgery
  • Plasminogen Activators / therapeutic use*
  • Retinal Hemorrhage / physiopathology
  • Retinal Hemorrhage / therapy*
  • Retrospective Studies
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome
  • Visual Acuity / physiology
  • Vitrectomy*

Substances

  • Plasminogen Activators
  • Tissue Plasminogen Activator